Investigating how a specific gene affects bone health and treatment responses in osteoporosis
The Nmp4 Anti-Anabolic Bone Axis R01AR070144-01A1
This study is looking at a gene called Nmp4 to see how it affects bone health and could help improve treatments for osteoporosis, which might lead to better options for people dealing with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10465066 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of the Nmp4 gene in bone health and its potential impact on osteoporosis treatments. By studying mice with a mutation in the Nmp4 gene, researchers aim to uncover why some osteoporosis therapies lose effectiveness over time and identify new molecular targets for drug development. The approach involves analyzing how the absence of Nmp4 enhances bone formation in response to various therapies, which could lead to improved treatment options for patients with osteoporosis. The findings may help in developing safer and more effective therapies for enhancing bone mass and reducing fractures.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals at risk of osteoporosis or those currently undergoing treatment for the condition.
Not a fit: Patients who do not have osteoporosis or related bone health issues may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and more effective treatments for osteoporosis, improving bone health and reducing the risk of fractures for patients.
How similar studies have performed: Previous research has shown promise in targeting molecular pathways related to bone health, suggesting that this approach could yield significant advancements in osteoporosis treatment.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Bidwell, Joseph P — Indiana University Indianapolis
- Study coordinator: Bidwell, Joseph P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.